Join
Live feed
·
INSIDERFilingvia Quantisnow
Denali Therapeutics Inc. logo

Director Van Hauwermeiren Timothy was granted 10,632 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DNLI· Denali Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DNLI (Denali Therapeutics Inc.) and more on Quantisnow.

Director Van Hauwermeiren Timothy was granted 10,632 shares (SEC Form 4) | Quantisnow